Merck KGaA's cladribine earns positive opinion from CHMP for relapsing forms of multiple sclerosis June 26, 2017
EMA's CHMP grants positive opinion for tivozanib for the first-line treatment of advanced RCC June 26, 2017
Alexion Pharmaceuticals receives positive opinion from EMA to extend Soliris indication June 26, 2017
RSS